Tenax Therapeutics Inc. appointed Anthony DiTonno CEO, effective June 1.
Michael Jebsen, the company's current interim CEO and CFO, will continue to serve as CFO after DiTonno's appointment.
DiTonno has been a director of Tenax since December 2011. He served as CEO of Avantis Medical Systems Inc., a medical device company that develops and manufactures catheter-based endoscopic devices, from January 2013 until May 31, 2018.
Morrisville, N.C.-based Tenax Therapeutics is a specialty pharmaceutical company, which focuses on the identification, development and commercialization of a portfolio of products for the critical care market.
